Trials / Completed
CompletedNCT06338956
Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 135,877 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
For the management of low-density lipoprotein-cholesterol (LDL-C), some guidelines recommend initial statin treatment with high-intensity statins to achieve at least a 50% reduction in LDL-C levels. High-intensity or maximally tolerated intensity can be maintained without a target goal. However, the European guideline recommends less than 55 mg/dL of LDL-C after PCI.
Detailed description
To investigate the Optimal Attained LDL-C Levels in Patients Who Achieved ≥50% LDL-C Reduction After PCI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LDL reduction therapy | LDL reduction therapy |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-12-31
- Completion
- 2025-05-15
- First posted
- 2024-04-01
- Last updated
- 2025-05-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06338956. Inclusion in this directory is not an endorsement.